Friess Associates »

Catalyst Pharmaceutical Partners shares owned by Friess Associates

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Friess Associates from 13F filings

Historical chart of Friess Associates investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Friess Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Friess Associates

Quarter filed Position value Share count Share price at filing
2022-06-30 $2.1M 305k 7.01
2022-03-31 $4.7M 572k 8.29

More positions owned by Friess Associates

Amphastar Pharmaceuticals (AMPH)
Acm Research (ACMR)
Stratasys (SSYS)
Kura Sushi Usa Inc cl a (KRUS)
Dhi (DHX)
Information Services (III)
Tecnoglass (TGLS)
Titan Machinery (TITN)
Caleres (CAL)
Assertio Holdings (ASRT)
Daseke
Catalyst Pharmaceutical Partners (CPRX)
Axogen (AXGN)
Napco Security Systems (NSSC)
Carriage Services (CSV)

View all positions for Friess Associates

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
Deerfield Management Company
State Street Corporation
Dimensional Fund Advisors
Pacer Advisors
Geode Capital Management
Renaissance Technologies
First Trust Advisors
Royce & Associates
Goldman Sachs Group
Northern Trust
Robeco Investment Management
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Catalyst Pharmaceutical Partners